Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9GMS

Mtb PNPase Rv2783c

This is a non-PDB format compatible entry.
Summary for 9GMS
Entry DOI10.2210/pdb9gms/pdb
EMDB information51454
DescriptorPolyribonucleotide nucleotidyltransferase, RNA (5'-R(P*AP*AP*AP*AP*AP*AP*AP*AP*AP*AP*AP*AP*AP*AP*A)-3'), 1-[[4-[4-[[2-phenyl-5-(trifluoromethyl)-1,3-oxazol-4-yl]carbonylamino]phenyl]phenyl]carbonylamino]cyclopentane-1-carboxylic acid (3 entities in total)
Functional Keywordspnpase, gpsi, rna degradosome, pnpase inhibitor, rna
Biological sourceMycobacterium tuberculosis
More
Total number of polymer chains4
Total formula weight196806.51
Authors
Griesser, T.,Sander, P. (deposition date: 2024-08-29, release date: 2025-06-25, Last modification date: 2025-07-09)
Primary citationGriesser, T.,Wang, R.,Angona, I.P.,Rogenmoser, J.,Obrist, J.,Schneider, G.,Sander, P.
Selective inhibition of Mycobacterium tuberculosis GpsI unveils a novel strategy to target the RNA metabolism.
Nucleic Acids Res., 53:-, 2025
Cited by
PubMed Abstract: Polyribonucleotide nucleotidyl-transferases (PNPases) play a critical role in the degradation of mRNA. The mycobacterial PNPase, guanosine penta-phosphate synthase I (GpsI), is an essential enzyme in Mycobacterium tuberculosis (Mtb), collaborating with endoribonucleases and helicases to process RNA. In this study, we identify GpsI as a novel and underexplored drug target. The inhibitor 1-(4'-(2-phenyl-5-(trifluoromethyl) oxazole-4-carboxamido)-[1,1'-biphenyl]-4-caroxamido) cyclopentane-1-carboxylic acid (X1), discovered through a whole-cell screening, specifically inhibits GpsI activity in biochemical assays. Biochemical and physiological analyses of engineered GpsI variants and recombinant Mycobacterium smegmatis pinpoint amino acids 328 and 527 as critical residues for the selective activity of X1 against Mtb complex. High-resolution cryo-electron microscopy analysis of the ternary GpsI-X1-poly(A) complex elucidates the drug-binding pocket, providing insight into its mechanism of action. This study introduces a potent inhibitor targeting the underexplored Mtb-GpsI and offers a molecular explanation for its selective specificity.
PubMed: 40530695
DOI: 10.1093/nar/gkaf529
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (1.98 Å)
Structure validation

245663

数据于2025-12-03公开中

PDB statisticsPDBj update infoContact PDBjnumon